MSA:NYSEMSA Safety Incorporated Analysis
Data as of 2026-05-31 - not real-time
$165.80
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
MSA posted a solid Q1 with revenue up 10% year‑over‑year to $463.6 million and a non‑GAAP EPS of $1.99, beating consensus estimates and reinforcing its strong operating margin of 22% and ROE of 22.8%. Fundamentals remain robust—cash flow is healthy, debt‑to‑equity sits at a manageable 48.6%, and the dividend has been increased for a 56th consecutive year, yielding 1.3% with a modest 28.6% payout ratio. Valuation is mixed: the trailing P/E of 22 is well below the industry average of 30, forward P/E contracts to 17, yet the DCF‑derived fair value of $113 is far beneath the current $165 price, suggesting the market may be pricing in growth expectations.
Technically, the stock trades just above its identified support at $164.4 and below the 20‑day SMA of $169.8, with a neutral RSI of 43 and a bearish MACD histogram, indicating short‑term downside pressure but ample room to the resistance around $179. Volatility is elevated at 28% over the past 30 days, though beta of 0.96 points to near‑market systematic risk.
Given the earnings momentum, strategic acquisition expanding fire‑ and gas‑detection capabilities, and a consistent dividend track record, the medium‑ to long‑term outlook is positive, while short‑term positioning should respect the near‑term technical weakness and stay near the support level.
Technically, the stock trades just above its identified support at $164.4 and below the 20‑day SMA of $169.8, with a neutral RSI of 43 and a bearish MACD histogram, indicating short‑term downside pressure but ample room to the resistance around $179. Volatility is elevated at 28% over the past 30 days, though beta of 0.96 points to near‑market systematic risk.
Given the earnings momentum, strategic acquisition expanding fire‑ and gas‑detection capabilities, and a consistent dividend track record, the medium‑ to long‑term outlook is positive, while short‑term positioning should respect the near‑term technical weakness and stay near the support level.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat supports price stability
- Technical indicators show bearish momentum near support
- Volatility is elevated, suggesting cautious positioning
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward earnings growth lowering PE to 17
- Analyst target price around $206 implies ~24% upside
- Strategic acquisition enhancing market positioning
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent dividend increases for 56 years indicate financial resilience
- Strong ROE and cash flow generation support sustainable growth
- Diversified end‑markets and expanding product portfolio reduce cyclicality
Key Metrics & Analysis
Financial Health
Revenue Growth10.00%
Profit Margin15.16%
P/E Ratio22.4
ROE22.83%
ROA11.34%
Debt/Equity48.57
P/B Ratio4.8
Op. Cash Flow$377.7M
Free Cash Flow$240.3M
Industry P/E29.9
Technical Analysis
TrendNeutral
RSI43.2
Support$164.37
Resistance$178.76
MA 20$169.81
MA 50$169.48
MA 200$171.64
MACDBearish
VolumeStable
Fear & Greed Index94.07
Valuation
Fair Value$113.32
Target Price$205.71
Upside/Downside24.07%
GradeFair
TypeBlend
Dividend Yield1.30%
Risk Assessment
Beta0.96
Volatility28.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.